The Claim
Creatine induces ferroptosis in colorectal cancer cells by binding to extracellular signal-regulated kinase 2 (ERK2), inhibiting its activation by MEK1, which reduces phosphorylation and stabilization of ferroptosis suppressor protein 1 (FSP1), leading to increased cancer cell death.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Creatine causes colorectal cancer cells to die through a specific biochemical pathway that disables a protein protecting cells from ferroptosis.
See the scientific wording
Creatine induces ferroptosis in colorectal cancer cells by binding to extracellular signal-regulated kinase 2 (ERK2), inhibiting its activation by MEK1, which reduces phosphorylation and stabilization of ferroptosis suppressor protein 1 (FSP1), leading to increased cancer cell death.
Creatine enters cancer cells and binds to a protein called ERK2, which stops another protein from activating it. Without activation, ERK2 cannot tag a protective protein called FSP1, causing FSP1 to break down. Without FSP1, harmful fat damage builds up in the cell until it dies.
What the research says
1 studyCreatine stops a cancer cell's protective system from working, which makes the cancer cells die in a specific way called ferroptosis. The study shows this happens exactly as described.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.